These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1109897)

  • 1. Mechanism of the effects of hypothalamic deafferentation on prolactin secretion in the rat.
    Krulich L; Hefco E; Aschenbrenner JE
    Endocrinology; 1975 Jan; 96(1):107-18. PubMed ID: 1109897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evidence on the role of the hypothalamic afferents on the estrogen-induced prolactin release.
    Caligaris L; Taleisnik S
    Neuroendocrinology; 1977; 23(6):323-9. PubMed ID: 22826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hypothalamic deafferentation on the secretion of thyrotropin in resting conditions in the rat.
    Hefco E; Krulich L; Aschenbrenner JE
    Endocrinology; 1975 Nov; 97(5):1226-33. PubMed ID: 810344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of porcine hypothalamic extract on prolactin release in the rat.
    Milmore JE; Reece RP
    Endocrinology; 1975 Mar; 96(3):732-8. PubMed ID: 803898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hypothalamic deafferentation on the secretion of thyrotropin during thyroid blockade and exposure to cold in the rat.
    Hefco E; Krulich L; Aschenbrenner JE
    Endocrinology; 1975 Nov; 97(5):1234-40. PubMed ID: 1183410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic deafferentation inhibits the stimulatory influence of prolactin on follicle-stimulating hormone release in the golden hamster.
    Carrillo AJ; Goldman BD; Bartke A
    Endocrinology; 1984 Jan; 114(1):87-91. PubMed ID: 6418527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.
    Soya H; Suzuki M
    Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical disconnection of the medial basal hypothalamus and pituitary function in the rhesus monkey. IV. Prolactin secretion.
    Bulter WR; Krey LC; Lu KH; Peckham WD; Knobil E
    Endocrinology; 1975 May; 96(5):1099-105. PubMed ID: 1122876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct inhibitory effect of long term estradiol treatment on dopamine synthesis in tuberoinfundibular dopaminergic neurons: in vitro studies using hypothalamic slices.
    Arita J; Kimura F
    Endocrinology; 1987 Aug; 121(2):692-8. PubMed ID: 3036480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of biogenic amines and TRH on release of prolactin and TSH in the rat.
    Chen HJ; Meites J
    Endocrinology; 1975 Jan; 96(1):10-4. PubMed ID: 803259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary prolactin secretion in female rats made persistently estrous or diestrous by hypothalamic deafferentation.
    Blake CA; Weiner RI; Sawyer CH
    Endocrinology; 1972 Apr; 90(4):862-6. PubMed ID: 5062326
    [No Abstract]   [Full Text] [Related]  

  • 12. [3H]Dihydroergocryptine binding in anterior pituitary and prolactin secretion: further evidence of brain regulation of adenohypophyseal receptors.
    Libertun C; Larrea GA; Vacas MI; Cardinali DP
    Endocrinology; 1980 Dec; 107(6):1905-9. PubMed ID: 6775933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peripheral noradrenergic terminal as possible site of action of salsolinol as prolactoliberin.
    Székács D; Bodnár I; Mravec B; Kvetnansky R; Vizi ES; Nagy GM; Fekete MI
    Neurochem Int; 2007 Jan; 50(2):427-34. PubMed ID: 17141375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive substance P content in median eminence and pituitary gland during oestrus, dioestrus and after anterior hypothalamic deafferentation.
    Antonowicz U; Jakubowska-Naziembło B; Cannon D; Powell D
    Endokrinologie; 1982 Feb; 79(1):25-34. PubMed ID: 6177528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of testosterone implants and hypothalamic lesions on luteinizing hormone regulation in the castrated male rat.
    Cheung CY; Davidson JM
    Endocrinology; 1977 Feb; 100(2):292-302. PubMed ID: 318993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hypothalamic deafferentation on circulating levels of LH, FSH, prolactin and testosterone in the male rat.
    Blake CA; Scaramuzzi RJ; Norman RL; Hilliard J; Sawyer CH
    Endocrinology; 1973 May; 92(5):1419-25. PubMed ID: 4695428
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of hypothalamic afferents in the release of prolactin induced by ovarian steroids.
    Caligaris L; Taleisnik S
    Neuroendocrinology; 1976; 21(2):139-45. PubMed ID: 1012438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary gonadotropin-releasing hormone (GnRH) receptor responses to GnRH in hypothalamus-lesioned rats: inhibition of responses by hyperprolactinemia and evidence that testosterone and estradiol modulate gonadotropin secretion at postreceptor sites.
    Pieper DR; Gala RR; Schiff MA; Regiani SR; Marshall JC
    Endocrinology; 1984 Sep; 115(3):1190-6. PubMed ID: 6086288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced dopamine synthesis and release in vitro in the median eminence of rat hypothalamus are associated with involution of estradiol-induced pituitary tumors.
    Arita J; Kojima Y; Kimura F
    Endocrinology; 1989 Apr; 124(4):1998-2004. PubMed ID: 2924731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.